By Alaric DeArment
NEW YORK — The Food and Drug Administration is concerned about bills in several state legislatures that seek to restrict pharmacists’ ability to dispense biosimilars, according to published reports.
Biopharma-Reporter.com quoted an FDA spokeswoman as saying “efforts to undermine trust in these products” were cause for worry and did not serve the interests of patients.
Source URL:
